ICER releases draft evidence report on therapies for severe asthma

16 September 2021 - Public comment period now open until 14 October 2021; requests to make oral comment during public ...

Read more →

EMA publishes agenda for 13-16 September CHMP meeting

13 September 2021 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

1 October 2021 price disclosure confirmed prices

13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...

Read more →

ICER publishes evidence report on treatments for myasthenia gravis

10 September 2021 - While eculizumab and efgartigimod each provide important health benefits, both would need to be priced more than ...

Read more →

PBAC Public Summary Documents (first time decisions not to recommend, deferrals and other matters) – May 2021 meeting

10 September 2021 - The Public Summary Documents (first time decisions not to recommend, deferrals and other matters) from the May ...

Read more →

MSAC publishes agenda for upcoming meeting

3 September 2021 - 12 agenda items for consideration at the 25-26 November 2021 meeting. ...

Read more →

Updated agenda for the November 2021 PBAC meeting

2 September 2021 - The agenda for the November 2021 PBAC meeting has been updated.  ...

Read more →

Public Summary Documents – May 2021 PBAC meeting

27 August 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2021 PBAC ...

Read more →

Method paper: IQWiG puts draft version 6.1 up for discussion

23 August 2021 - The IQWiG has presented the draft for the next version of its General Methods.  ...

Read more →

TGA reduces timeframe for publishing adverse event reports

19 August 2021 - With strong public interest in adverse event reports relating to COVID-19 vaccinations, and improvements in our ...

Read more →

ICER releases draft evidence report on mavacamten for hypertrophic cardiomyopathy

18 August 2021 - Public comment period now open until 15 September 2021; requests to make oral comment during public meeting ...

Read more →

Final guidance on metastasis-free survival in non-metastatic castration resistant prostate cancer released by the FDA

10 August 2021 - The FDA announced its finalised guidance on the use of metastases-free survival as an outcome for ...

Read more →

Version 4 and counting

9 August 2021 - The Department of Health has published yet another revised agenda for the November 2021 PBAC meeting. ...

Read more →

Updated financial estimates workbook

6 August 2021 - An updated version of the Utilisation and Cost Model workbook is now available to support PBAC submissions. ...

Read more →

DoH publishes revised agenda for Nov 2021 PBAC meeting

3 August 2021 - One week on and we are already up to version 3. ...

Read more →